Vascular endothelial growth factor effects on nuclear factor-κB activation in hematopoietic progenitor cells

Cancer Research

Volumn 61, Issue 5, 2001, Pages 2015-2021

  Dikov, Mikhail M ^a   Oyama, Tsunehiro ^a   Cheng, Pingyan ^b   Takahashi, Takamune ^a   Takahashi, Keiko ^a   Sepetavec, Tanya ^a   Edwards, Byard ^a   Adachi, Yasushi ^a   Nadaf, Sorena ^a   Daniel, Thomas ^a   Gabrilovich, Dmitry I ^b   Carbone, David P ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; COMPLEX FORMATION; DENDRITIC CELL; DNA BINDING; DRUG EFFECT; ELECTROPHORETIC MOBILITY; ENDOTHELIUM CELL; HEMATOPOIETIC CELL; HYPOXIA; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; STEM CELL;

ANIMALS; CELL NUCLEUS; DNA; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; FEMALE; HEMATOPOIETIC STEM CELLS; HUMANS; I-KAPPA B KINASE; I-KAPPA B PROTEINS; LYMPHOKINES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; RATS; RATS, WISTAR; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; TRANSCRIPTION FACTOR RELB; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035266375     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Vascular endothelial growth factor is a secreted angiogenic mitogen
2. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis
3. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model
4. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
5. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide
6. The biology of vascular endothelial growth factor
7. Clinical significance of the determination of angiogenic factors
8. Down-regulation of vascular endothelial growth factor in human colon carcinoma cell lines by antisense transfection decreases endothelial cell proliferation
9. Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients
10. Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-κB activation in hemopoietic progenitor cells
11. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
12. Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo
13. Regulation of the NF-κB/rel transcription factor and IκB inhibitor system
14. Rel/NF-κB/IκB family: Intimate tales of association and dissociation
15. Tyrosine phosphorylation of IκBα activates NF-κB without proteolytic degradation of IκBα
16. Nuclear factor (NF)-κ-B2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses
17. The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-κB-mediated inhibition
18. Expression of relB transcripts during lymphoid organ development: Specific expression in dendritic antigen-presenting cells
19. Expression of relB is required for the development of thymic medulla and dendritic cells
20. Dendritic cell progenitor is transformed by a conditional v-Rel estrogen receptor fusion protein v-RelER
21. Abnormal T lymphocyte development induced by targeted overexpression of IκBα
22. Mesangial cell behavior in a three-dimensional extracellular matrix
23. HMEC-1: Establishment of an immortalized human microvascular endothelial cell line
24. Tumor necrosis factor α and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor κB
25. A functionally defective allele of TAP1 results in loss of MHC class 1 antigen presentation in a human lung cancer
26. Elevated constitutive IκB kinase activity and IκBα phosphorylation in Hs294T melanoma cells lead to increased basal MGSA/GRO-α transcription
27. NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176
28. Site-specific tyrosine phosphorylation of IκBα negatively regulates its inducible phosphorylation and degradation
29. Positive and negative regulation of IκB kinase activity through IKKβ subunit phosphorylation
30. The IKKβ subunit of IκB kinase (IKK) is essential for nuclear factor κB activation and prevention of apoptosis
31. Myeloid progenitor cell regulatory effects of vascular endothelial cell growth factor
32. KDR receptor: A key marker defining hematopoietic stem cells
33. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors
34. Expression of novel surface antigens on early hematopoietic cells
35. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
36. SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types
37. Relationship between the expression of vascular endothelial growth factor and the density of dendritic cells in gastric adenocarcinoma tissue
38. In vitro angiogenic and proteolytic properties of bovine lymphatic endothelial cells
39. Vascular permeability factor, an endothelial cell mitogen related to PDGF
40. TNF-α stimulates monocyte adhesion to glomerular mesangial cells. The role of intercellular adhesion molecule-1 gene expression and protein kinases
41. Protein tyrosine kinases expressed in glomeruli and cultured glomerular cells: Flt-1 and VEGF expression in renal mesangial cells
42. Role of ascorbate in the activation of NF-κB by tumour necrosis factor-α in T-cells
43. 2+-dependent signal transduction pathways
44. Involvement of a putative protein-tyrosine phosphatase and IκBα serine phosphorylation in nuclear factor κB activation by tumor necrosis factor
45. IKKγ is an essential regulatory subunit of the IκB kinase complex
46. Complementation cloning of NEMO, a component of the IκB kinase complex essential for NF-κB activation
47. Differential regulation of IκB kinase α and β by two upstream kinases, NF-κB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1
48. The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells
49. HCPTPA, a protein tyrosine phosphatase that regulates vascular endothelial growth factor receptor-mediated signal transduction and biological activity
50. Protein phosphatase X interacts with c-Rel and stimulates c-Rel/nuclear factor κB activity
51. Differential interactions of Rel-NF-κB complexes with IκBα determine pools of constitutive and inducible NF-κB activity
52. Two distinct mechanisms contribute to the constitutive activation of RelB in lymphoid cells
53. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice
54. Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium